ClinicalTrials.Veeva

Menu

Efficacy of a Smartphone App. Designed to Manage Craving & Individual Predictors of Substance Use/Addictive Behavior (CRAVINGMANAGER)

C

Centre Hospitalier Charles Perrens, Bordeaux

Status

Enrolling

Conditions

Addiction

Treatments

Other: Smartphone application

Study type

Interventional

Funder types

Other

Identifiers

NCT04732676
2020-A01707-32

Details and patient eligibility

About

Test the Efficacy of a smartphone application designed to manage craving and individual predictors of substance use / addictive behavior among individuals with addictive disorders

Full description

This translational project is the clinical application of research results from the University of Bordeaux, Sanpsy Lab, CNRS USR3413 - on individual predictors of substance use. This project will test the efficacy of a smartphone application to help subjects concerned about reducing or stopping their substance use / behavioral addiction.

This new therapeutic tool, designed by University of Bordeaux, Sanpsy Lab, CNRS USR3413 - to manage craving and individual predictors of use, will offer the possibility of an easy to-use and personalized intervention accessible to the greatest number of subjects.

Based on our previous results that supports that, for all types of addiction, craving and individual cues are a significant drive for use in people with addiction, the application tested in this study was designed to be used among people presenting various types of addiction (substance and behavioral addictions). The application will also evaluate all concurrent substance uses and addictive behaviors to identify and prevent risk of addiction transfers.

Enrollment

274 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants requesting help for substance or behavioral addiction in one of the participating specialized addiction treatment centers, and with more than 1-month-delay before treatment admission
  • Age >= 18 years of age
  • With at least one substance or behavioral addiction (DSM-5 criteria)
  • Affiliated person or beneficiary of a social security scheme.
  • Free, informed and written consent signed by the participant and the investigator

Exclusion criteria

  • Medical, psychiatric or addiction condition that warrants immediate treatment intervention
  • Patients with somatic, cognitive or other disorders preventing the use of the device (deafness, impaired vision, illiteracy....)
  • Difficulty in understanding and / or writing French
  • Not familiar with the use of smartphone
  • Individuals participating in another study that includes an ongoing exclusion period
  • Be deprived of liberty due to an ongoing legal procedure
  • Individuals under legal protection
  • Be under guardianship or under curatorship

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

274 participants in 2 patient groups, including a placebo group

Experimental group
Experimental group
Description:
participants will receive and use during 4 weeks the full interventional version of the smartphone application (combining EMA + EMI) targeting craving and personal situations at risk for use
Treatment:
Other: Smartphone application
control group
Placebo Comparator group
Description:
: participants will receive and use a restricted version of the smartphone application (only EMA: 4 electronic questionnaires per day to assess main problematic substance use / addictive behavior) during 4 weeks
Treatment:
Other: Smartphone application

Trial contacts and locations

1

Loading...

Central trial contact

MARC AURIACOMBE, MD, Prof; AURELIEN VAUTARD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems